Luveris

Luveris is a brand name of lutropin alfa, approved by the FDA in the following formulation(s):

LUVERIS (lutropin alfa - injectable; subcutaneous)

• 
  Manufacturer: EMD SERONO
  
  Approval date: October 8, 2004
  
  Strength(s): 75 IU/VIAL ^[RLD]

Has a generic version of Luveris been approved?

No. There is currently no therapeutically equivalent version of Luveris available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Luveris. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof
  Patent 5,767,251
  Issued: June 16, 1998
  Inventor(s): Reddy; Vermuri B. & Hsiung; Nancy & Beck; Anton K. & Bernstine; Edward George
  Assignee(s): Genzyme Corporation
  Biologically active heterodimeric human fertility hormones composed of two different subunits, each subunit being synthesized in the same cell transformed by at least one cell expression vector having heterologous DNA encoding each subunit with each subunit being controlled by a separate promoter. Preferred human fertility hormones include hCG, hLH and hFSH.
  
  Patent expiration dates:
  
  
  • June 16, 2015
    
    ✓ 
    Drug substance
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • October 8, 2011 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Luveris Consumer Information (Drugs.com)
• Luveris Consumer Information (Wolters Kluwer)
• Luveris Consumer Information (Cerner Multum)
• Luveris Advanced Consumer Information (Micromedex)
• Luveris AHFS DI Monographs (ASHP)
• Lutropin Alfa Consumer Information (Wolters Kluwer)
• Lutropin alfa Consumer Information (Cerner Multum)
• Lutropin alfa Subcutaneous Advanced Consumer Information (Micromedex)
• Lutropin Alfa AHFS DI Monographs (ASHP)